Mounjaro vs Wegovy: Which Is Better for Weight Loss in 2026?

Available online. Shipped directly to your door anywhere in the US.

Mounjaro vs Wegovy: what is the difference?

Mounjaro is the brand name for tirzepatide, a dual GIP/GLP-1 receptor agonist made by Eli Lilly. Wegovy is the brand name for semaglutide 2.4 mg, a GLP-1 receptor agonist made by Novo Nordisk. Both are once-weekly injections used for weight loss, but they work through slightly different mechanisms.

Wegovy is FDA-approved specifically for chronic weight management. Mounjaro is FDA-approved for type 2 diabetes, but it is often prescribed off-label for obesity because it produces significant weight loss. The weight-loss brand of tirzepatide is Zepbound.

This guide compares Mounjaro vs Wegovy for people who want to lose weight and are trying to choose between these two popular medications.

How do Mounjaro and Wegovy work?

Both medications mimic natural gut hormones that regulate appetite, digestion, and blood sugar. The key difference is the number of hormone pathways they target:

• Wegovy (semaglutide): Activates GLP-1 receptors, reducing hunger, slowing stomach emptying, and improving blood sugar control.
• Mounjaro (tirzepatide): Activates both GLP-1 and GIP receptors. GIP may enhance insulin secretion and fat metabolism, which may explain the stronger average weight loss.

Clinical results: Mounjaro vs Wegovy weight loss

Clinical trials suggest tirzepatide produces greater average weight loss than semaglutide. In the SURMOUNT-1 trial, tirzepatide produced:

• 15% average weight loss at 5 mg
• 19.5% at 10 mg
• 20.9% at 15 mg

In the STEP-1 trial, Wegovy 2.4 mg produced about 14.9% average weight loss over 68 weeks. That is excellent, but the highest Mounjaro doses produced larger reductions on average.

Real-world studies and patient reports generally confirm this pattern. However, some individuals lose more weight on Wegovy than on Mounjaro. Personal response depends on genetics, starting weight, diet, side effect tolerance, and adherence.

Dosing schedules

Wegovy starts at 0.25 mg weekly and increases every 4 weeks to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg. Mounjaro starts at 2.5 mg weekly and increases to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

Both medications use slow titration to minimize nausea and other gastrointestinal side effects. Mounjaro has more dose steps, which can help providers fine-tune the balance between results and tolerability.

Side effects

Both Mounjaro and Wegovy cause similar side effects, including:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal discomfort
• Decreased appetite

Because tirzepatide is generally more potent, some patients experience slightly more nausea at higher Mounjaro doses. Both medications are usually well tolerated when doses are increased gradually and patients follow dietary guidance.

Cost without insurance

Without insurance, Wegovy and Mounjaro both retail for approximately $1,200 to $1,350 per month. Zepbound is in the same range. Insurance coverage varies widely, and many plans do not cover weight-loss medications.

For people paying cash, compounded semaglutide and compounded tirzepatide through telehealth programs are much cheaper, typically $150 to $400 per month. Read our cheapest GLP-1 guide for a full breakdown.

Mounjaro vs Wegovy comparison table

Who should choose Mounjaro?

Mounjaro may be the better choice if:

• You want the highest average weight loss based on clinical data
• You have insulin resistance or prediabetes
• You tolerate GLP-1 medications well
• You want a dual-hormone approach

Who should choose Wegovy?

Wegovy may be the better choice if:

• You want an FDA-approved weight-loss medication
• You prefer a medication with more long-term safety data
• You experienced side effects with tirzepatide
• Your insurance covers Wegovy

Can you switch from Wegovy to Mounjaro?

Yes, many patients switch between these medications under medical supervision. Common reasons include better weight loss on tirzepatide, fewer side effects on semaglutide, or cost and availability. A clinician will usually restart titration at a low dose to minimize side effects.

How to get Mounjaro or Wegovy online

You can get either medication through a licensed US telehealth weight-loss program. The process typically includes an online health questionnaire, provider review, prescription, and home delivery. Compounded versions are usually the most affordable option for cash-pay patients.

Frequently asked questions

Is Mounjaro better than Wegovy for weight loss?

On average, yes. Clinical trials show greater weight loss with tirzepatide than with semaglutide. However, individual results vary.

Can I get Mounjaro prescribed for weight loss?

Mounjaro is approved for diabetes, but providers may prescribe it off-label for weight loss. Zepbound is the weight-loss brand of tirzepatide. Telehealth programs can evaluate your eligibility.

Does insurance cover Mounjaro or Wegovy?

Coverage varies. Some plans cover Wegovy or Mounjaro for obesity or diabetes. Many patients use cash-pay telehealth programs or compounded alternatives.

Which has fewer side effects, Mounjaro or Wegovy?

Wegovy is often slightly better tolerated because it is less potent. Mounjaro can cause more nausea at higher doses but also tends to produce more weight loss.

What is the cheapest alternative to Mounjaro and Wegovy?

Compounded semaglutide and compounded tirzepatide through telehealth programs are typically the cheapest legal options.

Conclusion

Both Mounjaro and Wegovy are effective GLP-1 medications for weight loss. If average weight loss is your priority, Mounjaro (tirzepatide) has the stronger clinical data. If you prefer an FDA-approved weight-loss drug with more long-term data, Wegovy (semaglutide) is an excellent choice. The best medication is the one that fits your health profile, goals, and budget.

Ready to compare options? Check your eligibility for a US telehealth GLP-1 program and get your medication shipped directly to your door.